India's fiscal deficit for April-November was at ₹8.47 trillion, 52.5% of the estimate for FY25, according to data released by Controller General of Accounts (CGA) on Tuesday. This is lower than the ₹9.07 trillion a year ago due to Reserve Bank of India (RBI) dividend and subdued government capex during the first quarter amid the general elections, though tax receipts remained somewhat flat.
The Union government's fiscal deficit target is 4.9% of the gross domestic product (GDP) for 2024-25 (FY25), as announced by finance minister Nirmala Sitharaman in the Union budget 2024-25 against the 5.6% in 2023-24, which was lower than the revised estimates of 5.8%.
During the April-November period, net tax receipts stood at ₹14.43 trillion, or 56% of the target set in the annual budget in July, against ₹14.36 trillion in the same period of the previous year, CGA data showed.
Total government expenditure during the period was ₹27.41 trillion, or 57% of the annual target, against ₹26.52 trillion in the year-ago period.
Diese Geschichte stammt aus der January 01, 2025-Ausgabe von Mint Bangalore.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der January 01, 2025-Ausgabe von Mint Bangalore.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars
Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects
DIAL drops plea over Hindon ops expansion
Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.
Auto sales rise 9% in 2024 despite headwinds: Fada
Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec
Razorpay Charts Return to India; Eyes Expansion, IPO
Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years
Bank profits set to moderate in FY26 as bad assets rise
Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier
Lloyds Metals shines on likely gains from acquisition, capex
Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.
Another tough year for FMCG?
Feeling blue
Your fancy, new ETF might be a little too fancy
Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good
Risks to economy escalating in 2025, cautions SBICAPS
Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report
Intas Pharma bags another overseas company
Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.
